Literature DB >> 17306868

Effect of physiologic shear stresses and calcium on agonist-induced platelet aggregation, secretion, and thromboxane A2 formation.

Delia Viisoreanu1, Adrian Gear.   

Abstract

INTRODUCTION: Platelets in vivo react under low-shear venous-flow as well as high-shear arterial-flow conditions. Because most studies were carried out at low shear stresses, platelet granule secretion at high shear has not been examined thoroughly. We investigated the secretion of all three types of platelet granules and thromboxane A(2) formation at high shear after stimulation with ADP or thrombin.
MATERIALS AND METHODS: Washed human platelets were reacted rapidly (<5 s) in a quenched-flow system simulating high-shear arterial-flow conditions (30 dyn/cm(2)). For comparison, we employed a low-shear stirring system (1-5 dyn/cm(2)). Serotonin release and membrane exposure of P-selectin (alpha), CD63 (dense), and CD107a (lysosomes) were used to assess granule secretion. Aggregation was evaluated by resistive-particle counting of the remaining platelet singlets. RESULTS AND
CONCLUSIONS: ADP and thrombin induced similar strong levels of aggregation ( approximately 70%) at high shear by 5 s. Thrombin also caused release of about 40% of all alpha and dense granules within 5 s. However, by 5 s at high shear, ADP failed to induce significant granule secretion or thromboxane A(2) formation (<5%, p>0.05). By 10 min at low shear, ADP caused secretion and thromboxane A(2) formation only at non-physiological, micromolar extracellular Ca(2+) concentrations. These results emphasize the ability of thrombin to initiate multiple aspects of platelet function within seconds, while ADP was only able to induce rapid aggregation.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17306868     DOI: 10.1016/j.thromres.2007.01.007

Source DB:  PubMed          Journal:  Thromb Res        ISSN: 0049-3848            Impact factor:   3.944


  6 in total

1.  Effects of MDMA and related analogs on plasma 5-HT: relevance to 5-HT transporters in blood and brain.

Authors:  Samanta Yubero-Lahoz; Mario A Ayestas; Bruce E Blough; John S Partilla; Richard B Rothman; Rafael de la Torre; Michael H Baumann
Journal:  Eur J Pharmacol       Date:  2011-11-03       Impact factor: 4.432

Review 2.  Antiplatelet drug 'resistance'. Part 2: laboratory resistance to antiplatelet drugs-fact or artifact?

Authors:  Diana A Gorog; Joseph M Sweeny; Valentin Fuster
Journal:  Nat Rev Cardiol       Date:  2009-04-14       Impact factor: 32.419

3.  Shear-Mediated Platelet Activation is Accompanied by Unique Alterations in Platelet Release of Lipids.

Authors:  Alice Sweedo; Lisa M Wise; Yana Roka-Moiia; Fernando Teran Arce; S Scott Saavedra; Jawaad Sheriff; Danny Bluestein; Marvin J Slepian; John G Purdy
Journal:  Cell Mol Bioeng       Date:  2021-08-25       Impact factor: 3.337

4.  Platelet function tests: why they fail to guide personalized antithrombotic medication.

Authors:  Diana A Gorog; Young-Hoon Jeong
Journal:  J Am Heart Assoc       Date:  2015-05-26       Impact factor: 5.501

5.  Chlorin e6 Prevents ADP-Induced Platelet Aggregation by Decreasing PI3K-Akt Phosphorylation and Promoting cAMP Production.

Authors:  Ji Young Park; Hyun Dong Ji; Bo Ra Jeon; Eun Ju Im; Young Min Son; Joo Young Lee; Dong-Ha Lee; Young-Chul Lee; Eujin Hyun; Qi Jia; Mei Hong; Hwa-Jin Park; Man Hee Rhee
Journal:  Evid Based Complement Alternat Med       Date:  2013-08-13       Impact factor: 2.629

6.  Platelets and the Cybernetic Regulation of Ischemic Inflammatory Responses through PNC Formation Regulated by Extracellular Nucleotide Metabolism and Signaling.

Authors:  Tiago F Granja; David Köhler; Veronika Leiss; Claudia Eggstein; Bernd Nürnberg; Peter Rosenberger; Sandra Beer-Hammer
Journal:  Cells       Date:  2022-09-27       Impact factor: 7.666

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.